Comparing 3 vs. 4 brachytherapy sessions for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two different schedules of brachytherapy (a type of internal radiation) for cervical cancer. It aims to see if a shorter course of 3 treatments works just as well as the standard 4 treatments, which could mean fewer visits and less discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cervical cancer and be scheduled to receive a type of radiation called brachytherapy as part of your main treatment.
- You should be 18 years old or older.
- You should be able to take care of yourself with little to no help (ECOG score 0–2).
- You cannot have had radiation to your pelvic area in the past 3 months.
- You must be able to have an MRI (no metal implants or other reasons that would prevent it).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (fewer sessions) after hysterectomy for cervical cancer. It aims to see if it's safe and effective for patients who meet certain criteria based on their tumor type and recovery.
This trial tests a special type of radiation, called brachytherapy, given in 3 sessions using thin needles. It is for people with cervical cancer that has not spread too far, and who have already had standard radiation treatment.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial tests two different radiation schedules for women with high-risk cervical cancer after surgery. The goal is to see if a shorter course of radiation works as well as or better than the standard longer course, while possibly being more convenient.
This trial compares two types of radiation boost therapy for locally advanced cervical cancer: a newer, precise type called SABR versus the standard brachytherapy. The goal is to see if SABR works as well or better with fewer side effects.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
Hear when a new Cervical Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.